New York, NY, United States of America

Paul J Tiseo

This inventor holds 2 USPTO granted patents. Top assignee: Eisai Company, Limited. Active years: 2002-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul J Tiseo. Retrieved from https://idiyas.com/inventor/paul-j-tiseo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2002-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paul J Tiseo: Innovator in Attention Disorders Treatment

Introduction

Paul J Tiseo is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of disorders of attention. With a total of 2 patents, Tiseo's work focuses on innovative methods to improve attention in humans.

Latest Patents

Tiseo's latest patents include novel methods of using cholinesterase inhibitors to treat disorders of attention. The first patent outlines methods for administering an effective amount of a cholinesterase inhibitor to improve attention in humans. The second patent similarly provides methods for treating attention disorders through the use of cholinesterase inhibitors.

Career Highlights

Paul J Tiseo is currently associated with Eisai Company, Limited, where he continues to develop and refine his innovative approaches to treating attention disorders. His work has the potential to impact many individuals suffering from these conditions.

Collaborations

Tiseo has collaborated with notable colleagues, including Lawrence Tim Friedhoff and Sharon L Rogers, to advance his research and innovations in the field.

Conclusion

Paul J Tiseo's contributions to the treatment of attention disorders through his innovative patents highlight his role as a significant inventor in the medical field. His work continues to pave the way for advancements in therapeutic methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…